Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €15.04 EUR
Change Today +0.19 / 1.28%
Volume 0.0
1SF6 On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 2:09 AM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

psychemedics corp (1SF6) Snapshot

Open
€15.04
Previous Close
€14.85
Day High
€15.04
Day Low
€15.04
52 Week High
03/18/15 - €15.56
52 Week Low
09/17/14 - €9.98
Market Cap
80.8M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
5.4M
EX-Date
02/19/15
P/E TM
--
Dividend
€0.57
Dividend Yield
3.14%
Current Stock Chart for PSYCHEMEDICS CORP (1SF6)

Related News

No related news articles were found.

psychemedics corp (1SF6) Related Businessweek News

No Related Businessweek News Found

psychemedics corp (1SF6) Details

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company’s testing methods utilize a patented technology that focuses on digesting hair and releasing drugs trapped in the hair without destroying the drugs. The company’s tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, and opiates, including heroin, hydrocodone, hydromorphone, oxycodone, and codeine. Psychemedics Corporation offers its services to employers for applicant and employee testing; physicians, treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children’s drug use; and Fortune 500 companies and small to mid-size corporations. The company was founded in 1985 and is headquartered in Acton, Massachusetts.

156 Employees
Last Reported Date: 02/27/15
Founded in 1985

psychemedics corp (1SF6) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $500.4K
Vice President of Laboratory Operations
Total Annual Compensation: $289.2K
Corporate Vice President of Sales & Marketing
Total Annual Compensation: $235.0K
Compensation as of Fiscal Year 2013.

psychemedics corp (1SF6) Key Developments

Psychemedics Corp. Reports Unaudited Earnings Results for Fourth Quarter and Full Year Ended December 31, 2014

Psychemedics Corp. reported unaudited earnings results for fourth quarter and full year ended December 31, 2014. The company's revenue for the fourth quarter ended December 31, 2014 was $6.8 million versus $6.5 million for the quarter ended December 31, 2013, an increase of 4%. Net income and comprehensive income was $676,000 or $0.13 per diluted share, versus $867,939 or $0.16 per diluted share, for the comparable period last year, a decrease of 22%. Operating income was $957,670 against $1,033,155 a year ago. Net income before provision for income taxes was $930,251 against $1,033,435 a year ago. The company's revenue for the year ended December 31, 2014 was $29.2 million versus $26.9 million for the twelve months ended December 31, 2013, an increase of 9%. Net income and comprehensive income was $3.2 million or $0.60 per diluted share, versus $3.8 million or $0.72 per diluted share, for the comparable period last year, a decrease of 16%. Operating income was $4,689,641 against $5,706,365 a year ago. Net income before provision for income taxes was $4,633,065 against $5,798,638 a year ago.

Psychemedics Corporation Declares Quarterly Dividend, Payable on March 6, 2015

Psychemedics Corporation announced a quarterly dividend of $0.15 per share payable to shareholders of record as of February 23, 2015 to be paid on March 6, 2015.

Psychemedics Corp. Presents at 17th Annual Needham Growth Conference, Jan-15-2015 08:40 AM

Psychemedics Corp. Presents at 17th Annual Needham Growth Conference, Jan-15-2015 08:40 AM. Venue: New York Palace Hotel, 455 Madison Avenue, New York, New York, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1SF6:GR €15.04 EUR +0.19

1SF6 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alliance HealthCare Services Inc $22.18 USD +0.03
Enzo Biochem Inc $2.95 USD -0.08
Genomic Health Inc $30.55 USD -0.34
NeoGenomics Inc $4.67 USD -0.13
Response Genetics Inc $0.44 USD 0.00
View Industry Companies
 

Industry Analysis

1SF6

Industry Average

Valuation 1SF6 Industry Range
Price/Earnings 27.5x
Price/Sales 3.0x
Price/Book 6.9x
Price/Cash Flow 27.5x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PSYCHEMEDICS CORP, please visit www.psychemedics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.